GHRP-2
GHRP-2 is studied as a growth hormone secretagogue acting upon the ghrelin receptor. Current evidence explores its influence on GH induction alongside broader collateral endocrine responses.
Limited HumanEndocrine ResearchNeuroscience Research
Formula
C₄₅H₅₅N₉O₆
MW
817.95 g/mol
Half-life
≈15–60 min (literature)
Studies
2
Research Material · Uptide.eu
View Research Material →Access product specifications, COA documentation and research material on Uptide.
Research overview
GHRP-2 is a synthetic growth hormone-releasing peptide operating as a potent agonist of the growth hormone secretagogue receptor (GHS-R), effectively functioning within the same receptor network as endogenous ghrelin. Scientific investigation looks critically at elicited GH secretion, rigorous appetite regulation, complex hypothalamic-pituitary interactions, and secondary markers including prolactin, ACTH, and cortisol. In human experimental protocols, GHRP-2 serves as an investigational compound to understand underlying ghrelin-like physiological mechanisms and appetite signaling. Because GHRP-2 is not completely endocrine selective, experimental profiles reflect its broad multi-axis physiological impact rather than functioning solely as an isolated growth or recovery agent.
Synonyms
Pralmorelin, KP-102
Classification
Synthetic growth hormone-releasing peptide
Molecular weight
817.95 g/mol
Molecular formula
C₄₅H₅₅N₉O₆
CAS Number
158861-67-7
Half-life
≈15–60 min (literature)
Evidence level
Limited Human
Research areas
Endocrine Research, Neuroscience Research
Pathways
GHSR signalling, Hypothalamic-pituitary-adrenal axis
Related compounds
Frequently co-cited in the literature
Research disclaimer
All information is provided for educational and scientific research purposes only. No content constitutes medical advice, treatment recommendations, administration guidance or dosing recommendations. Products referenced are intended for laboratory and analytical research.